BioConnetiX connects the complex ecosystem of care providers required to transform fragmented, costly micro-diagnostics into evidence-based, personalized care from a foundation in molecular science. It is the first healthcare platform of its kind to harness physician, scientist and operator specialization to comprehensively manage the entire continuum of care. Extensive partner collaboration with payors, healthcare networks, research institutions, molecular pathologists & microbiologists, and laboratory operators is paramount in our ability to capture the full value of analytic medicine.

Clinical standards and value are addressed by integrating foundations from medical practice into advanced diagostics and personalized medicine through regimented operational deployment. Pricing risk is offloaded from payers by BioConnetiX. Utilization outlier detection, telehealth-driven workup and care plan management occur upon deployment and progress through a series of increasingly ambitious operational, clinical and financial thresholds. Clinical pathways are supported with sophisticated decision-support technology. Specialization, standardization, centralization, and alignment with credentialed laboratories allow for dramatically reduced costs and timely, consistent performance. Analytics measures report user adherence to protocols, clinical and financial outcomes, benchmark performance data, and a growing set of other measures.

Conventional systems lack the structure to integrate micro-level diagnostics into consistent, evidence-based care at scale – limiting their value in optimizing treatment.

• Primary care providers and networks cannot manage the volume and complexity of requirements needed for care based on molecular diagnostics.
• Independent laboratories lack the resources to connect lab-developed tests into a scalable, consistently-managed and evidence-based clinical pathway.
• Research institutions & sub-specialists excel at discovery but are not structured to operationalize results into everyday clinical practice.

BioConnetiX gives healthcare networks and payors a proven method to optimize the management of costly, complex disease processes.

• Measured, staged implementation of evidence-based workflows
• Integrated systems and care networks powered by technology for consistent, cost-effective management at scale
• Effective long-term pathway management with the option for full financial risk assumed by BioConnetiX

Providing tailored solutions that integrate seamlessly into your network

• Pathway Design & Implementation
• Identify costly or complex disease processes better managed through pathway-driven care
• Consult to define specific pathways and connect the right resources
• Implement evidence-based pathways tailored to your network
• System Integration & Automation
• Connect systems and automate workflows across your network
• Deploy decision-support tools for consistent, efficient management
• Build remote sub-specialty networks to augment provider teams with expert oversight and long-term monitoring
• Analytics & Population Management
• Develop KPIs, dashboards, and biobanking services
• Apply AI/ML models for risk pattern identification and advanced learning
• Deliver population-level dashboards for proactive, data-driven management

The Result:
As systems advance, BioConnetiX delivers deeper insights and additional metrics, empowering advanced care, optimized outcomes, and smarter coverage and policy decisions.

Insurance companies piloting BioConnetiX frameworks for specific clinical pathways see near-term cost savings and deep impact. Our targeted programs can address high-cost injuries and disease processes without the delays of legacy infrastructure – delivering early wins while building scalable models. Results data from these programs refine Early Warning Score (EWS) indicators, drug-dose guidance, and other clinical protocols across the network, continuously reducing risk and cost.